Published in Acta Orthop Scand on April 01, 2001
Thromboprophylaxis in hip arthroplasty. New frontiers and future strategy. Acta Orthop Scand (1998) 2.95
Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand (2000) 1.42
Thromboembolism--an academic concern or a clinical reality? Acta Orthop Scand (1999) 0.92
Low-molecular weight heparin as prophylaxis against thromboembolism after total hip replacement--is it worth the price? Acta Orthop Scand (2000) 0.90
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost (2007) 3.66
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management. Ann Intern Med (1994) 3.44
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet (1993) 3.41
Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ (1991) 3.14
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
Liver transplantation after paracetamol overdose. BMJ (1991) 2.81
Solitary aneurysms of the iliac arterial system: an estimate of their frequency of occurrence. J Vasc Surg (1989) 2.69
A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg (1985) 2.61
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg (2010) 2.52
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med (2001) 2.37
A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med (1992) 2.27
Pulmonary artery catheterization and mortality in critically ill patients. Br J Anaesth (2000) 2.09
Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis? Am J Obstet Gynecol (1989) 2.06
Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study. J Thromb Haemost (2005) 2.03
Pulmonary artery flow directed catheter: the evidence. Lancet (1996) 2.02
Ruptured abdominal aortic aneurysm: a population-based study. J Vasc Surg (1993) 2.00
[Problems of interpretation in vascular surgery]. Lakartidningen (1993) 1.94
Antithrombotic therapy for venous thromboembolic disease. Chest (2001) 1.94
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res (2010) 1.93
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest (1985) 1.92
Cranial nerve injuries after carotid artery surgery. A prospective study of 663 operations. Eur J Vasc Endovasc Surg (1995) 1.86
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med (1999) 1.80
Venous and non-venous leg ulcers: clinical history and appearance in a population study. Br J Surg (1994) 1.79
Heparin induced thrombosis: an important complication of heparin prophylaxis for thromboembolic disease in surgery. BMJ (1993) 1.72
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost (2005) 1.70
Recommendations on biosimilar low-molecular-weight heparins. J Thromb Haemost (2009) 1.68
[Clinical diagnosis of deep venous thrombosis after hip replacement surgery]. Tidsskr Nor Laegeforen (1997) 1.67
Antithrombotic therapy for venous thromboembolic disease. Chest (1998) 1.67
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med (1986) 1.67
A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol (2006) 1.62
Changing concepts in renovascular surgery. Br J Surg (1989) 1.58
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. J Thromb Haemost (2003) 1.57
Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br (2006) 1.56
Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg (1988) 1.53
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med (1983) 1.51
Prevalence of abdominal aortic aneurysm in the offspring of patients dying from aneurysm rupture. Br J Surg (1992) 1.51
Nationwide study of the outcome of popliteal artery aneurysms treated surgically. Br J Surg (2007) 1.51
Iatrogenic vascular injuries in Sweden. A nationwide study 1987-2005. Eur J Vasc Endovasc Surg (2007) 1.49
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.48
Upper gastrointestinal haemorrhage in Oxford. A prospective study. J R Coll Surg Edinb (1984) 1.48
Validity of an exam assessment in surgical skill: EBSQ-VASC pilot study. Eur J Vasc Endovasc Surg (2004) 1.48
Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor. Plast Reconstr Surg (1995) 1.46
Randomized clinical trial of routine preoperative duplex imaging before varicose vein surgery. Br J Surg (2005) 1.46
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost (2009) 1.45
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost (2006) 1.44
Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med (1994) 1.44
Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol (2004) 1.44
Insurance claims after vascular surgery in Sweden. Eur J Vasc Endovasc Surg (2011) 1.43
Acute thrombogenicity of collagen coating of dacron grafts: an experimental study in sheep. Eur J Vasc Surg (1992) 1.41
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests. Am J Med (2000) 1.40
An experimental porcine model of partial ischaemia of the distal colon. Eur J Surg (1997) 1.39
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet (1994) 1.39
Complications after carotid endarterectomy are related to surgical errors in less than one-fifth of cases. Swedvasc--The Swedish Vascular Registry and The Quality Committee for Carotid Artery Surgery. Eur J Vasc Endovasc Surg (1999) 1.38
Increasing prevalence of abdominal aortic aneurysms. A necropsy study. Eur J Surg (1992) 1.38
Amputation for premature peripheral atherosclerosis: do young patients do better? Lancet (1996) 1.37
Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg (1991) 1.36
Fatal nonocclusive mesenteric ischaemia: population-based incidence and risk factors. J Intern Med (2006) 1.35
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.34
Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg (1993) 1.33
Continuous venovenous high-flux dialysis in multiorgan failure: a 5-year single-center experience. Am J Kidney Dis (1998) 1.32
Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ (1994) 1.30
Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet (1992) 1.29
Incidence and clinical presentation of bowel ischaemia after aortoiliac surgery--2930 operations from a population-based registry in Sweden. Eur J Vasc Endovasc Surg (1996) 1.26
Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis (1990) 1.26
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke. Lancet (1987) 1.25
Arterial complications after knee arthroplasty: 4 cases and a review of the literature. Acta Orthop Scand (1996) 1.25
Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery (1994) 1.22
Outcome after hemiarthroplasty for three- and four-part fractures of the proximal humerus. J Shoulder Elbow Surg (1998) 1.21
Economic evaluation of enoxaparin as postdischarge prophylaxis for deep vein thrombosis (DVT) in elective hip surgery. Value Health (2006) 1.20
Vascular complications after total hip arthroplasty. Acta Orthop Scand (1983) 1.19
Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg (2005) 1.19
Self-assessment of technical skill in surgery: the need for expert feedback. Ann R Coll Surg Engl (2008) 1.18
Risk factors for intestinal ischaemia after aortoiliac surgery: a combined cohort and case-control study of 2824 operations. Eur J Vasc Endovasc Surg (1997) 1.17
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. J Thromb Haemost (2004) 1.17
Antithrombotic therapy for venous thromboembolic disease. Chest (1995) 1.17
Prospective study of the quality of life in patients assessed for liver transplantation: outcome in transplanted and not transplanted groups. J R Soc Med (1995) 1.15
Incidence and prevalence of abdominal aortic aneurysms, estimated by necropsy studies and population screening by ultrasound. Ann N Y Acad Sci (1996) 1.14
Incidence of acute thrombo-embolic occlusion of the superior mesenteric artery--a population-based study. Eur J Vasc Endovasc Surg (2004) 1.13
Effectiveness of the Quick Medical Reference as a diagnostic tool. CMAJ (1999) 1.13
Diameter and compliance in the male human abdominal aorta: influence of age and aortic aneurysm. Eur J Vasc Surg (1992) 1.13
Antithrombotic therapy for venous thromboembolic disease. Chest (1989) 1.12
Ultrasonographic screening of the abdominal aorta among siblings of patients with abdominal aortic aneurysms. Br J Surg (1989) 1.12
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial. Ann Intern Med (1985) 1.11
Adult respiratory distress syndrome--how many cases in the UK? Anaesthesia (1988) 1.10
Strategy for diagnosis of patients with suspected acute pulmonary embolism. Chest (1993) 1.10
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty. J Thromb Haemost (2010) 1.08
Development and validation of an elbow score. Rheumatology (Oxford) (2004) 1.08
Complications in breast augmentation: prevention and correction. Clin Plast Surg (2001) 1.06
Prevention of deep vein thrombosis after hip replacement. Thromb Haemost (2000) 1.06
Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial. World J Surg (1997) 1.06
Intimal hyperplasia recurs after removal of PDGF-AB and -BB inhibition in the rat carotid artery injury model. Arterioscler Thromb Vasc Biol (2000) 1.06
Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran. Thromb Res (2008) 1.05